Melbourne's Peter MacCallum Cancer Centre to be home of 'the next great wave in treatment'

25 March 2019 - A new form of cancer treatment that uses cell therapy to attack the disease will become ...

Read more →

NICE nod for Takeda’s Adcetris in advanced stage CTCL

22 March 2019 - Takeda has announced the NICE recommendation of its advanced cutaneous T-cell lymphoma drug Adcetris (brentuximab vedotin). ...

Read more →

Genmab announces European regulatory submission for daratumumab in combination with lenalidomide and dexamethasone in frontline multiple myeloma

22 March 2019 - Type II variation application submitted to the EMA for daratumumab in combination with lenalidomide and dexamethasone as ...

Read more →

A patient’s journey with melanoma and drug coverage concerns

22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...

Read more →

PBAC report - Options for listing PD-(L)1 checkpoint inhibitors for multiple cancer indications on the PBS

22 March 2019 - The PBAC Report to the Minister for Health on “Options for listing PD(L)-1 checkpoint inhibitors for multiple ...

Read more →

NICE terminates yet another assessment of a cancer medicine

20 March 2019 - This time it is pembrolizumab (Keytruda). ...

Read more →

York man Paul Thomas-Peter says he could die because NHS won't fund drug

19 March 2019 - A York cancer patient says he could die because the NHS refuses to fund immunotherapy treatment ...

Read more →

Cancer Society slams PHARMAC's treatment of patients

20 March 2019 - The Cancer Society says New Zealand patients are worse off than those in Australia. ...

Read more →

FDA approves Genentech’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer

18 March 2019 - First new initial treatment option approved by the U.S. FDA for people with ES-SCLC in more than ...

Read more →

New treatment option now available in Canada for newly diagnosed patients with advanced lung cancer

18 March 2019 - Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy reduced the risk of death by half compared ...

Read more →

Three new drugs added to PBS to ease cost pain

19 March 2019 - Three new treatments to help save or prolong the lives of thousands of Australians suffering from ...

Read more →

New early breast cancer drug to reduce risk of recurrence or death approved for Australian women

18 March 2019 - Nerlynx (neratinib) now approved by the Therapeutic Goods Administration for Australian women. ...

Read more →

Women with advanced breast cancer ask the PM to intervene

15 March 2019 - On Wednesday 13 March, ten women with advanced breast cancer presented to the Health Select Committee to ...

Read more →

Karyopharm announces FDA extension of review period for selinexor new drug application

14 March 2019 - PDUFA action date extended by three months to July 6, 2019. ...

Read more →

One in four cancer patients wait two months for treatment, as NHS performance hits record low

14 March 2019 - The number of cancer sufferers waiting at least two months for treatment after an urgent referral ...

Read more →